Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors [Phase 2]

View source ↗

Summary

Phase II clinical trial of FCN-159 for NF2-related nerve sheath tumors is currently recruiting at the Cancer Institute and Hospital, Chinese Academy of Medical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FCN-159

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Nerve Sheath Tumor | Phase 2 | Status: RECRUITING